Market Research Blog – Page 1391 – New Product Development

Global Single Serve Coffee Container Market to Reach USD 1.61 Billion by 2033, Driven by Convenience and Growing Demand in the Food Service Industry

Single-serve coffee containers, also known as coffee pods, coffee capsules, or coffee pods, are individual portions of coffee grounds enclosed in a pre-measured package designed for use in single-serving coffee machines. These containers revolutionized the coffee industry by offering convenience, consistency, and customization to coffee lovers worldwide.

The global single serve coffee container market is set to experience significant growth over the next decade, with market value projected to increase from USD 779.6 million in 2023 to USD 1,613.7 million by 2033, according to the latest industry report by Future Market Insights (FMI). The market, which was valued at USD 726.6 million in 2022, is expected to exhibit a robust year-on-year growth rate of 7.3% in 2023. Over the projection period from 2023 to 2033, global single serve coffee container sales are likely to soar at a compound annual growth rate (CAGR) of 7.5%.

The single serve coffee container market, a dynamic segment of the global coffee industry, is rapidly expanding due to growing consumer demand for convenience and quality. These containers, designed to brew a single portion of coffee, offer a practical solution for both consumers and businesses, ensuring freshness and simplifying the brewing process.

Furthermore, the surging utilization of single-serve coffee containers across commercial sectors, including hotels, restaurants, cafes, and similar establishments, is poised to be a driving force behind market expansion. As the preference for on-the-go and versatile coffee solutions gains momentum, it contributes to the dynamic and robust growth of the single-serve coffee container market.

The disposable nature of single-serve coffee containers is also a significant industry development driver. Another potential driver is the growing demand for specialty coffee and single-serve methods.

Key Factors

The convenience provided by single-serve coffee containers stands out as a significant driver expected to swiftly propel the target market.

The rapid growth of the beverage sector coupled with an increasing demand for flexible packaging is poised to bolster the sales of single-serve coffee containers.

Furthermore, the emergence of eco-friendly options in the form of single-serve coffee containers represents a key trend that is anticipated to further fuel the expansion of the market.

Key Takeaways

By product type, sachets are anticipated to create an incremental opportunity of US$ 183.6 million through 2033.
Based on material, plastic containers are expected to comprise 58.6% market share by 2023.
By end use, food service outlets are projected to create an incremental opportunity of US$ 472.2 million through 2033.
The United States single-serve coffee containers industry to offer an incremental opportunity of US$ 98.24 million.
Single-serve coffee container demand in the United Kingdom will likely rise at 5.7% CAGR through 2033.

Drivers:

Consumer Convenience: Single-serve coffee containers provide convenience and ease of use, allowing consumers to quickly brew a fresh cup of coffee without the need for extensive preparation.
Growth in the Coffee Industry: The global coffee industry has been experiencing substantial growth, and single-serve containers are a key product in this market, catering to the evolving preferences of coffee enthusiasts.
Variety of Beverage Options: Single-serve containers are versatile and can be used for a wide range of hot and cold beverages, from coffee and tea to specialty drinks and hot chocolate.
On-the-Go Lifestyles: As more people adopt busy lifestyles, single-serve coffee containers cater to the need for portable and easy-to-use coffee solutions, such as for commuters and office workers.
Hospitality and Commercial Sector Demand: Hotels, restaurants, cafes, and other commercial establishments use single-serve coffee containers to meet the coffee preferences of their customers, contributing to market expansion.

Access Full Report: https://www.futuremarketinsights.com/reports/singleserve-coffee-containers-market

Global Single Serve Coffee Container Market by Category

By Product Type:

Coffee Capsules
Sachets
Stick Packs
Tubes/Vials/Jar

By Material:

Plastic
- Polyethylene (PE)
- Polypropylene (PP)
- Bioplastic
Paper
Fabric
Aluminum

By Size/Capacity:

0.5ml to 5ml
5.1ml to 15ml
Above 15ml

By Sales Channel:

Manufacturers (Direct Sales)
Distributors
- E-retail
- Bricks and Mortars Store

By End Use:

Food Service Outlets
- Quick Service Restaurants
- Hotels
- Cafes
Institutional (Offices, Multiplexes, etc.)
Household

By Region:

North America
Latin America
East Asia
South Asia & Pacific
Western Europe
Eastern Europe
Central Asia
Russia & Belarus
Balkan & Baltic Countries
Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Food Bags Market to Reach USD 1.59 Billion by 2033, Driven by Rising Demand in Foodservice Outlets and Ready-to-Eat Meal Segments

The global food bags market is set for substantial growth over the next decade, with market size expected to expand from USD 824.0 million in 2023 to USD 1,594.3 million by 2033, according to the latest industry report. The market, which was valued at USD 770.4 million in 2022, is projected to exhibit a robust year-on-year growth rate of 7.0% in 2023. Over the forecast period from 2023 to 2033, global food bag sales are anticipated to increase at a compound annual growth rate (CAGR) of 6.8%.

Core Concepts in the Food Bags Industry

Top Trend: The rising popularity of eco-friendly food bags is driving market trends.
Common Material: Plastic is the most frequently used material for making food bags.
Opportunities in the U.S.: The increase in online food delivery culture creates lucrative opportunities in the United States market.
Sales Drivers: Advancements in packaging technology are propelling sales.
Growth Forecast: The market is expected to register a CAGR of 6.8% through 2033.

Key Market Insights:

Robust Incremental Growth Opportunity: The food bags market is expected to generate an attractive incremental growth opportunity of US$ 823.9 million, expanding 2.1 times its current market value by 2033.
Dominance of Foodservice Outlets: By end-use, the foodservice outlets segment is anticipated to hold a significant share of about 47.8% by 2033. This growth is driven by the rising usage of food bags in food service establishments such as restaurants and hotels.
High Demand for Disposable Food Bags: The disposable food bags segment commands a market share of 71.1% and is expected to thrive at a CAGR of about 6.5% over the forecast period, reflecting the high global demand for convenient and hygienic packaging solutions.

Key Market Shaping Factors:

Growing Demand from Takeaway Food Service Outlets and Households: The increasing preference for takeaway food and the convenience it offers is driving the demand for food bags. Households are also contributing to this growth with their need for efficient food storage solutions.
Focus on Food Safety and Cross-Contamination Reduction: There is a rising emphasis on improving food safety standards and minimizing cross-contamination risks, which is boosting the demand for food bags.
Popularity of Ready-to-Eat and Ready-to-Cook Meals: The surge in the popularity of ready-to-eat and ready-to-cook meals is bolstering food bag sales, as these products require reliable and convenient packaging solutions.
Influence of Cooking Shows and Celebrity Chefs: The global food bags market is benefiting from the influence of popular cooking shows and celebrity chefs, which are driving consumer interest in innovative and practical food packaging.
Stringent Food Safety Regulations: The implementation of stringent food safety regulations worldwide is fostering market development by necessitating the use of high-quality food bags.
Rising Demand for Oven Bags and Online Food Delivery: The growing popularity of oven bags and the booming online food delivery sector are stimulating market growth. Food bags ensure that meals remain fresh and intact during transportation.

Market Trends and Future Outlook

The demand for food bags is expected to surge due to the increasing adoption of innovative packaging solutions by ready-to-cook food and meal kit manufacturers. The rise of catering and food delivery services has created a high demand for packaging solutions that can maintain the quality and freshness of meals during transportation. This trend is anticipated to fuel the demand for food bags over the assessment period.

Similarly, the rising adoption of food bags in households is expected to boost the global food bags industry during the projection period. The exponential growth of e-commerce and food delivery is another prominent factor creating growth prospects for global food bag manufacturing companies.

The following are the prominent manufacturers of food bags listed in the report.

Amcor Plc
Reynolds Consumer Products Inc.
Sealed Air Corporation
Sirane Limited
M&Q Packaging, LLC
FFP Packaging Ltd.
Melitta Group AG
Sunkey Corporation
Aalmir Plastic Industries LLC
Al Bayader International
EcoPack
HDK Packaging Co., Ltd.
Flexipol
Handgards
S. C. Johnson & Son, Inc.
The Clorox Company,

Access Full Report: https://www.futuremarketinsights.com/reports/food-bags-market

Global Food Bags Market Segmentation

By Material Type:

Nylon
Plastic
Aluminum
Paper
Silicon

By Bag Type:

Disposable
Reusable

By Size:

Small
Medium
Large

By Sales Channel:

Online
Offline
- Supermarket/Hypermarket
- Convenience Stores
- Others

By End Use:

Food Service Outlets
- Food Service Restaurant
- Quick Service Restaurant
- Catering Services
- Hotels and Lodgings
- Food Courts
- Others
Institutional Food Services
- Hospital
- Offices
- School
Household

About Future Market Insights (FMI)

Contact Us:

Global EPE Foam Market to Reach USD 2.1 Billion by 2033, Driven by Growing Demand in Automotive and Consumer Electronics Sectors

According to the latest research by Future Market Insights, the global expanded polyethylene (EPE) foam market is projected to experience steady growth over the next decade. The market, valued at USD 1.4 billion in 2023, is expected to reach USD 2.1 billion by 2033, registering a compound annual growth rate (CAGR) of 4.1% during the forecast period.

This market overview explores the factors propelling the growth of the EPE Foam Packaging Market, including the increasing demand for protective packaging solutions, the rise in e-commerce activities, and the versatility of EPE foam in meeting diverse packaging needs. Additionally, it delves into the competitive landscape, technological trends, and emerging applications that contribute to the dynamics of the EPE foam packaging industry.

As per the latest research by Future Market Insights, the global EPE (Expanded Polyethylene) foam packaging market is poised for significant growth. Projections indicate a compound annual growth rate (CAGR) of 4.1% during the forecast period, with the market value anticipated to rise from US$ 1.4 billion in 2023 to US$ 2.1 billion by 2033.

In particular, the global EPE foam packaging market is expected to be valued at US$ 1.4 billion in 2023. EPE foam packaging involves the utilization of expanded polyethylene foam as a protective packaging solution across various end-user applications. EPE foam is cherished for its lightweight, durability, and flexibility, which makes it a popular choice in the packaging industry. It excels in shock absorption, thermal insulation, and water resistance, enhancing its appeal in the packaging sector.

The surging interest in eco-conscious and sustainable packaging solutions stands as a pivotal driving force behind the EPE (Expanded Polyethylene) foam packaging market. EPE foam is recognized for its recyclable and reusable properties, contributing to a reduction in the volume of waste produced by packaging materials. This eco-friendly characteristic positions EPE foam as an attractive choice for environmentally conscious consumers and businesses alike.

Market Drivers:

Product Protection: EPE foam is known for its excellent shock absorption and protective properties, making it indispensable for the packaging of fragile and sensitive goods.
E-commerce Growth: The surge in e-commerce activities has increased the need for protective and cushioning packaging materials, where EPE foam is valuable for safeguarding products during shipping.
Lightweight and Insulating: EPE foam is lightweight and offers insulation, making it an attractive choice for a variety of industries, including electronics and automotive.
Sustainability Concerns: As sustainability gains importance, EPE foam is being produced using more environmentally friendly processes and materials, boosting its appeal.
Versatility: EPE foam can be molded and cut into various shapes and sizes, making it versatile for different packaging needs.

Growth Opportunities

The food and beverage industry is another major consumer of EPE foam packaging. With the escalating demand for packaged food and beverages, the EPE foam packaging market is poised for robust growth. The increasing prevalence of online food ordering and home delivery services has further propelled the demand for EPE foam packaging within this sector. As consumer preferences evolve and industries prioritize safety and efficiency, EPE foam packaging continues to play a pivotal role in catering to these diverse needs.

The EPE (Expanded Polyethylene) foam packaging market is experiencing a surge in growth opportunities, with the construction industry being a notable sector of expansion. EPE foam is gaining prominence as an insulation material in construction applications, primarily attributed to its exceptional thermal and acoustic insulation properties.

In addition to construction, EPE foam’s lightweight and shock-absorbing characteristics position it as the material of choice for packaging automotive parts during transportation. This application ensures the safe and secure transit of valuable auto components.

Market Demand

Insulation packaging is meticulously designed to shield products from the adverse effects of temperature fluctuations, moisture, and environmental factors that could compromise their quality and integrity.

One of the primary drivers behind the escalating demand for insulation packaging is the surging necessity for temperature-controlled packaging solutions. Numerous goods, encompassing items like food, pharmaceuticals, and medical devices, mandate precise temperature conditions to uphold their quality and efficacy. Insulation packaging emerges as a pivotal solution to maintain these products at the requisite temperature during their transit and storage.

Key Players

Mefron Technologies
Flexipack Group
Snehal Packaging Industry
Vento Foam Pvt. Ltd.
Foamtech
ESD Goods
Sinkery Foam
PAX Solutions
Leenol
Anu Industries
INTCO Recycling
Suzhou Hi-tech Zone Chuangfei Packaging Technology Co., Ltd.

Access Full Report:

Market Segmentation

Product Type:

Inserts
Corner & Edge Protectors
Foam Sheets
Anti-Static ESD Foam
Food Disposables

Distribution Channel:

Manufacturers (Direct Sales)
Distributors
Brick & Mortar Stores
E-retail

End Use:

Packaging
- Food Service
  - Trays
  - Clamshells
  - Plates
  - Bowls
  - Cups
- Protective Packaging
  - Wrapping
  - Cushioning
  - Insulation
Building & Construction
Furniture
Sports & Recreation
Other Industrial

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Dental Practice Management Software Market Set for Robust Growth, Projected to Reach USD 6.74 Billion by 2033 at a 10.25% of CAGR

The dental practice management software market is poised for significant expansion, with projections estimating its value to rise from USD 2.54 billion in 2023 to USD 6.74 billion by 2033. This growth represents a substantial compound annual growth rate (CAGR) of 10.25% over the forecast period.

The market’s impressive growth is driven by various factors, including the increasing adoption of digital solutions in dental practices, the need for streamlined operational processes, and enhanced patient management capabilities. The adoption of advanced technology is transforming dental practices, making them more efficient and patient-centric.

It can be integrated with X-ray sensors, intraoral cameras, imagers, and other dental equipment to keep patient records electronically. Today, dental practice management software runs in the cloud as software as a service (SaaS) or apps, eliminating the need to store patient information on paper and allowing doctors to access data remotely.

The growing awareness of oral hygiene has led to an increase in dental examinations worldwide. This is one of the key factors supporting the growth of the market along with the increasing number of the elderly population prone to developing oral diseases and oral diseases.

The ease of paying, booking, and updating information via easy-to-use online portals further fuels the market’s growth. Additionally, integrating IT solutions into oral health services has increased the demand for dental practice management software to reduce clinical errors and improve care delivery.

Cloud-based dental office management software is gaining traction due to its multiple benefits, such as charts and images, claims to track, and automatic claim reminders. The adoption of paperless digital dentistry is gaining ground, which is expected to positively impact market growth in the coming years.

Key Takeaways:

The web-based segment dominated the market with a 55.6% share in 2022. This is due to its low cost, enhanced security, fast updates, and unlimited storage space. Increasing adoption of DPM software in dental practices for billing, reporting, patient records, scheduling, and treatment planning is expected to drive the growth of the segment.
North America leads the overall market with a 40.4% revenue share in 2022. The strategic presence of key players such as Henry Schein One & Curve Dental and baby boomers’ rapid adoption of oral care services is one of the key factors driving United States market growth. Additionally, increased funding for start-ups is likely to support market growth.
The European market is also expected to grow significantly due to rapid technological progress and increased purchasing power. In the 24 months to 30 June 2020, 21 million adults and 6.3 million of their children visited his NHS dentist, according to UK NHS dental statistics.
In 2022, the dental clinic segment was likely to be the market leader, accounting for over 47.4% of total revenue. The industry is growing due to the increasing number of dental offices using dental office management software worldwide.

Manufacturers are constantly expanding their supply chains

The dental laser market’s competitive landscape is moderately fragmented, with a few major companies operating on a global and regional scale. Strategic alliances are being formed by key players in order to expand their respective portfolios and gain a strong foothold in the global market.

Latest Developments:

In June 2021, Curve Dental announced an agreement with Dental Intelligence to provide access to Dental Intelligence’s online appointment scheduling system, LocalMed. The purpose of the partnership is to make it easier for dental companies to use Curve Dental’s practice management software, which enables patients to virtually confirm appointments.
Henry Schein announced in May 2021 the development of axiUm Dental Software to integrate dental and medical patient records. New consistency in car modules improves electronic patient file interoperability and information exchange between dentistry and healthcare.
Edge Health Solution Inc. partnered with Allscripts in December 2020 to bring enterprise practice management software to her over 1,000 dentists nationwide to customize patient smiles.

Key Players :

Henry Schein, Inc.
Carestream Dental, LLC
DentiMax
Practice-Web, Inc.
Nextgen Healthcare, Inc.
ACE Dental Software
Datacon Dental Systems, Inc.
CareStack (Good Methods Global Inc.)
CD Nevco, LLC (Curve Dental)
Dentiflow

A Old Full Report Analysis Click Here

Key Segments:

Deployment Mode Outlook:

On-premise
Web-based
Cloud-based

Application Outlook:

Patient Communication
Invoice/Billing
Payment Processing
Insurance Management
Others

End-use Outlook:

Dental Clinics
Hospitals
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan (APEJ)
Japan
Middle East & Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

U.S. Concierge Medicine Market Projected to Reach USD 17.97 Billion by 2033 at a 10.32% of CAGR

The U.S. concierge medicine market is set to experience substantial growth, with projections estimating its value to reach USD 17.97 billion by 2033. The market is expected to thrive with a compound annual growth rate (CAGR) of 10.32% from 2023 to 2033. In the near term, concierge medicine sales in the United States are anticipated to reach USD 6.73 billion by the end of 2023.

Concierge medicine, a model offering personalized and accessible healthcare services, is gaining traction as more individuals seek high-quality, patient-centered care. The significant growth forecast reflects increasing demand for customized healthcare solutions and the ongoing shift towards premium, accessible medical services.

Concierge Medicine is Ideal for Both Patients and Doctors

Both patients and medical professionals win from concierge medicine. As a result, many concierge doctors are converting to this method. The United States has between 10,000 and 25,000 clinicians or subscription-based services, claims Concierge Medical Today, LLC.

Several female doctors are converting to concierge practice. Female physicians experience greater stress and burnout. Concierge medicine’s growing popularity is primarily due to physician burnout.

Enhancing patient awareness, improving disposable income, and expanding demand for quality healthcare services are projected to stimulate concierge medicine demand in the United States. Due to these perks, millennials are becoming more interested in concierge practice, strengthening the demand for concierge medicine in the United States.

Hybrid Concierge Approach Resolves Issue of Paucity of Primary Care Physicians

The hybrid concierge approach satisfactorily addresses primary care physician shortages. In the hybrid model, the primary care physician offers patients the option to select either subscription-based treatment or conventional care covered by insurance.

Access to healthcare may be challenging due to the physician shortage, leading many patients to concierge physicians for more accessible care. Even in a physician shortage, the subscription-based model may guarantee simple access to care. The United States concierge medicine market is believed to be powered by it.

Key Takeaways:

The primary care segment in the specialty category accounts for a considerable United States concierge medicine market share of 25.6% in 2023.
Physicians downgrade membership-based medicine to reduce stress and improve the overall patient experience. This is likely to amplify specialty category growth in the coming years.
In 2023, the group sector in the ownership category had 64.1% of the market.
Doctors combine offices with concierge medical organizations because converting to a retainer model demands legal compliance, advertising, and patient communication. This is positively influencing the ownership segment’s expansion.

Competitive Analysis

With many solo and group concierge physicians, the United States concierge medicine industry is fragmented. Concierge care providers are constantly working to attract famous healthcare professionals to increase membership volume. The leading United States concierge medicine market manufacturers’ common growth strategies are partnership and physician engagement.

Modern Developments

Partnership

Castle Connolly Private Health Partners (CCPHP) and Banner Health announced a partnership to launch the Banner Beyond Program in February 2022. The program offers members a customized and practical experience in a state-of-the-art concierge setting.

Acquisition

Businesses like Crossover Health and Signature MD in the United States concierge medicine industry concentrate on funding and acquisition.

Collaboration

By March 2021, Cypress Membership Medicine and Signature MD announced their planned merger in association with Blue Sea Capital. The merger helped SignatureMD maintain its leading position as a provider of concierge medical services.

A Old Full Report Analysis Click Here

Key Players:

MDVIP
Signature MD
Crossover Health
Specialdocs Consultants, LLC
PartnerMD
Concierge Consultants & Cardiology
Castle Connolly Private Health Partners
Peninsula Doctor
Cambell Family Medicine
Destination Health
Priority Physicians, Inc.
USA San Diego Health

Key Segments

By Specialty:

Primary Care
Pediatrics
Osteopathy
Internal Medicine
Cardiology
Psychiatry
Others

By Ownership:

Standalone
Group

By Region:

North America
Latin America
Asia Pacific
Middle East and Africa
Europe

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

CAR T-Cell Therapy Market Set for Significant Growth, Projected to Reach USD 6.82 Billion by 2033 at a 7% of CAGR

Chimeric Antigen Receptor T-Cell Therapy Market

The global chimeric antigen receptor (CAR) T-cell therapy market , valued at USD 2.54 billion in 2022, is expected to experience robust growth, reaching USD 3.5 billion by the end of 2023 and eventually accumulating USD 6.82 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 6.9% over the forecast period from 2023 to 2033. The market saw a CAGR of 7% during the historical period from 2018 to 2022.

The expansion of the CAR T-cell therapy market is driven by technological advancements and the rising demand for personalized medicine. CAR T-cell therapy, a groundbreaking treatment for various cancers, has shown significant promise in clinical outcomes, fueling its adoption and market growth.

The prospect of long-term remissions is another advantage of CAR T-Cell Therapy. In certain cases, CAR T-Cell Therapy has resulted in total remission, which implies that there is no evidence of cancer in the body. This is especially hopeful for people who have relapsed or refractory cancer and have exhausted all other treatment options.

As additional clinical trials are completed and drugs are licenced, the market for CAR T-Cell Therapy is expected to grow in the future years. In addition to the two currently approved drugs, several more CAR T-Cell Therapy treatments for different cancers are in late-stage clinical trials. Advances in gene editing technology are also expected to enhance the industry, enabling for the development of more effective CAR T-cell therapies with fewer side effects.

Key Takeaways from the Market Study

The Chimeric antigen receptor (CAR) T-Cell Therapy market is estimated to expand at a 6.9% CAGR from 2023 to 2033.
Yescarta is predicted to have 45% of the market share for Chimeric antigen receptor (CAR) T-Cell Therapy in 2023.
In 2023, North America is estimated to hold 45% of the market for Chimeric antigen receptor (CAR) T-Cell Therapy.
In 2023, Europe’s Chimeric Antigen Receptor (CAR) T-Cell Therapy market is estimated to account for 39% of the total.

“The increasing incidence of cancer, rising demand for personalized medicine, and advancements in CAR T-Cell Therapy are some of the major factors driving the growth of the market,” states an FMI analyst.

Competitive Landscape

Key players in the Chimeric antigen receptor (CAR) T-Cell Therapy market are Abbott Laboratories, Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Fresenius SE & Co. KGaA, Johnson & Johnson, Medtronic PLC, Novartis AG, Endo International PLC and Pfizer Inc.

BD has contributed to CAR T-Cell Therapy is through its flow cytometry technology, which is used to monitor the manufacturing and quality control of CAR T-cell therapies. Flow cytometry is a technique that allows researchers and clinicians to analyze and sort individual cells based on their physical and chemical characteristics. BD offers a range of flow cytometry instruments and reagents that are used to monitor the T-cells used in CAR T-Cell Therapy, as well as the cancer cells targeted by these therapies.
Boston Scientific has contributed to CAR T-Cell Therapy through its interventional oncology products. These products are designed to treat cancer through minimally invasive procedures, such as tumor ablation or embolization. While these procedures are not directly related to CAR T-Cell Therapy, they can be used to manage complications that may arise during or after CAR T-cell treatment, such as bleeding or swelling in the liver.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global chimeric antigen receptor (CAR) T-Cell Therapy market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

A Old Full Report Analysis Click Here

Key Segments Profiled in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Survey

By Type:

Abecma
Breyanzi
Kymriah
Tecartus
Yescarta
Others

By Application:

Leukemia
Lymphoma
Multiple Myeloma
Autoimmune Disorders
Other Application

By End User:

Hospitals
Cancer Care Treatment Centers

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Cancer Vaccines Market Poised for Remarkable Growth, Projected to Reach USD 24.22 Billion by 2033 at a 12% of CAGR

The global cancer vaccines market is set for substantial growth, with an anticipated market value of USD 9 billion in 2023 and projections indicating a rise to USD 24.22 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 12% over the forecast period from 2023 to 2033. The market experienced a CAGR of 9% during the historical period from 2018 to 2022.

The accelerating growth of the cancer vaccines market is driven by increasing investments in research and development, advancements in vaccine technology, and a growing emphasis on preventive and therapeutic cancer care. The rise in cancer incidence and the urgent need for effective treatment options are also contributing to the market’s expansion.

The cancer vaccine market is driven by factors such as increasing incidence of cancer, growing awareness about cancer vaccines, and government initiatives to promote cancer research and development. One of the key factors driving the growth of the cancer vaccine market is the increasing incidence of cancer worldwide. This is due to a variety of factors, such as aging populations, changing lifestyle patterns, and environmental factors. As the incidence of cancer continues to rise, there is a greater need for effective cancer treatments, including cancer vaccines.

Government initiatives are also playing a significant role in driving the growth of the cancer vaccine market. Governments around the world are investing heavily in cancer research and development, which has led to increased funding for cancer vaccine development and clinical trials. For example, the US government has launched the Cancer Moonshot initiative, which aims to accelerate cancer research and improve cancer treatment and prevention.

Key Takeaways from the Market Study
•The market for cancer vaccines expanded at a 9% CAGR from 2018 to 2022.
•The market for cancer vaccines is anticipated to expand at a 12% CAGR from 2023 to 2033.
•The market for cancer vaccines is anticipated to reach US$ 24.22 billion by 2033.
•Recombinant cancer vaccines have the biggest market share, according to the Future Market Insights research.
•For the market for cancer vaccines, North America is anticipated to hold a 40% market share.
•With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Cancer Vaccines.” says an FMI analyst

Market Competition
Key players in the market include companies such as Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, GlaxoSmithKline plc, Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Vaccinogen, Inc., F Hoffmann-La Roche AG, and OSE Immunotherapeutics, along with healthcare providers and technology companies among other global players.

•In January 2023, the U.K. government announced a collaboration with BioNTech, a German company, to trial potential vaccines for cancer and other illnesses, while campaigners cautioned that any breakthrough must remain affordable and accessible. Personalized mRNA therapies, including cancer vaccines that aim to activate the immune system against harmful cells, will be tested on cancer patients in England at both early and late stages. The therapies target active cancer cells and work to prevent their return. BioNTech will establish new research and development centers in the U.K., including a laboratory in Cambridge and a headquarters in London, and aim to supply 10,000 therapies to patients from September 2023 until the end of the decade.

The firm developed one of the most widely-distributed Covid-19 vaccines in collaboration with U.S. pharmaceutical firm Pfizer. The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.

More Insights Available
FMI, in its new offering, presents an unbiased analysis of the global Cancer Vaccines market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Technology, Treatment Method, Application & Region.

Key Segments Profiled in the Cancer Vaccines Industry Survey
Technology:
•Recombinant Cancer Vaccines
•Whole-cell Cancer Vaccines
•Viral Vector & DNA Cancer Vaccines
•Antigen/Adjuvant Cancer Vaccines

Treatment Method:
•Preventive Vaccine
•Therapeutic Vaccine

Application:
•Prostate Cancer
•Cervical Cancer
•Other Applications

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Severe Asthma Treatment Market Set for Significant Growth, Projected to Reach USD 36.18 Billion by 2033 at a 5.1% of CAGR

The global severe asthma treatment market is poised for notable expansion, with an anticipated market value of USD 22 billion in 2023 and a projected increase to USD 36.18 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 5.1% over the forecast period from 2023 to 2033. The market experienced a CAGR of 3.3% during the historical period from 2018 to 2022.

The growth in the severe asthma treatment market is driven by the increasing prevalence of asthma and the broad range of treatment options available. Advances in medical research and development, along with improved treatment modalities, are contributing to the market’s expansion.

Some of the most commonly used biologics for severe asthma treatment are omalizumab, mepolizumab, reslizumab, benralizumab, and dupilumab. These medications have been found to improve lung function, reduce asthma exacerbations, and improve overall quality of life in severe asthma patients when administered subcutaneously or intravenously.

The global Severe Asthma Treatment market is predicted to develop in the future years as more people are diagnosed with severe asthma and more breakthrough medications become available.

Key Takeaways:

The market for Severe Asthma Treatment is expected to increase at a 5.1% CAGR between 2023 and 2033.
In 2023, it is expected that the inhaled route of administration would account for 40% of the severe asthma therapy market.
North America is expected to retain 45% of the market for severe asthma therapy in 2023.
Europe’s market for Severe Asthma Treatment is expected to account for 39% of the total by 2023.

“Advancements in treatments along with innovation of treatment options is expected to favor the growth of the market in the upcoming years.” states an FMI analyst

Competitive Landscape

Key players in the Severe Asthma Treatment market are Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma, Morphosys, Roche, Avalo Therapeutics, Suzhou Connect Biopharmaceuticals, Pieris Pharma, Biosion

GlaxoSmithKline’s discovery and marketing of a biologic drug called Nucala has been one of the company’s most significant breakthroughs in the treatment of severe asthma (mepolizumab). Nucala is an anti-IL-5 monoclonal antibody that is used to treat severe eosinophilic asthma, which is characterised by high eosinophil levels in the blood and airways.
Novartis’ most major contribution to the treatment of severe asthma (omalizumab) has been the development and commercialization of a biologic medication called Xolair. Xolair is a monoclonal anti-IgE antibody that is used to treat severe allergic asthma caused by allergens such as pollen, dust mites, and animal dander.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Severe Asthma Treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

Key Segments:

Drug Class:

Reslizumab
Benralizumab
Anti-inflammatory

Route of Administration:

Oral
Inhaled
Intravenous
Subcutaneous

Device Type:

Dry powder inhalers
Metered dose inhalers
Soft mist inhalers

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Demand for Glucose Monitoring Devices Market Expected to Surge, Projected to Reach USD 44.6 Billion by 2034 at a 10.3% of CAGR

As the global diabetes burden continues to escalate, the demand for accurate and efficient glucose monitoring devices is set to experience significant growth. According to Future Market Insights’ latest report, the global glucose monitoring devices market is projected to expand at a compound annual growth rate (CAGR) of 10.6% over the next decade. The market value is expected to rise from USD 16.2 billion in 2024 to USD 44.6 billion by 2034.

The market, valued at USD 14.7 billion at the end of 2023, is anticipated to exhibit a robust year-over-year growth rate of 10.3% in 2024, reflecting a continued rise in demand for advanced glucose monitoring solutions. This growth is driven by the increasing prevalence of diabetes globally and the need for precise and user-friendly monitoring tools to manage the condition effectively.

One of the key contributors to the escalating costs associated with diabetes management is the need for regular monitoring. FMI’s report emphasizes that leveraging technologies such as information and communication, artificial intelligence, and smart devices can play a pivotal role in reducing these monitoring costs.

The adoption of continuous glucose monitoring devices, which are emerging as a novel technique for monitoring glucose levels, is growing along with the number of diabetic patients. Every ten minutes, these devices update the real-time glucose level data they provide. The preservation of healthy blood glucose levels is the only method for a diabetic to prevent potentially fatal diabetic complications, and glucose monitoring is an essential component of diabetes management.

Non-invasive glucose monitoring has recently become more popular as it lessens the discomfort and suffering experienced by diabetics who must prick their skin more than four times per day to measure their blood glucose levels.

With the increasing prevalence of diabetes, as well as advancements in sensor-based technologies for patient monitoring, the market is set to expand at a lucrative pace, over the forecast period.

Key Takeaways from Global Glucose Monitoring Devices Industry Study

Self-monitoring devices are the leading segment as a product, and hold approximately 3% market value share in 2022, owing to their automated and reliable monitoring process.
The diabetes type II segment is set to lead in terms of indication of glucose monitoring devices with an estimated market value share of around 1% by 2023, owing to the high prevalence of type II diabetes globally.
By end users, hospitals held a market share of around 7% in 2022, owing to the adoption of continuous monitoring devices in hospitals to reduce the number of fingersticks point-of-care capillary blood glucose tests, hyperglycemic episodes, and hypoglycemic episodes.
North America holds a value share of 0% in 2022, owing to the high prevalence of chronic diseases in the region.

“Rising initiatives to integrate artificial intelligence, as well as digital technologies to blood glucose monitoring devices, as well as growing new product launch activities, are factors propelling the growth of the global glucose monitoring market,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Global Glucose Monitoring Devices Industry Competition

Key players’ rigorous research led to the development of improved technologies such as flash glucose monitoring and continuous glucose monitoring. Companies also engage in strategic initiatives such as new product launches and mergers and acquisitions.

All consumers with diabetes type 1 are now covered by the Dexcom G6 rtCGM System under the Non-Insured Health Benefits Program, according to an announcement made by Dexcom, Inc. in January 2023.
Abbott disclosed in June 2022 that it is creating a new wearable that combines a sensor to continually monitor both glucose and ketone levels. The U.S. FDA has granted the system breakthrough device classification.

Key Global Glucose Monitoring Devices Industry Players:

Dexcom, Inc.
Abbott Laboratories
F. Hoffmann-La Roche Ltd (Switzerland)
Medtronic
Ascensia Diabetes Care
Arkray
Ypsomed AG
Acon Laboratories
Nipro
Nova Biomedical
Goldsite Diagnostics Inc. (China)
Lifescan Ip Holdings, LLC
Prodigy Diabetes Care
Others

A Old Full Report Analysis Click Here

Key Market Segments Covered in Global Glucose Monitoring Devices Industry Research

Product:

Self-Monitoring Devices
Continuous Monitoring Devices

Indication:

Diabetes Type I
Diabetes Type II

End User:

Hospitals
Clinics
Diagnostics Centres
Home Care Settings

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Whim Syndrome Management Market Poised for Growth, Projected to Reach USD 17.91 Million by 2033 at a 6% of CAGR

The global Whim Syndrome management market , valued at USD 10 million in 2023, is set to experience significant growth, with forecasts indicating an increase to USD 17.91 million by 2033. This growth represents a compound annual growth rate (CAGR) of 6% over the forecast period from 2023 to 2033, compared to a CAGR of 4% during the historical period from 2018 to 2022.

Whim Syndrome, a rare and complex immunodeficiency disorder, is gaining increasing attention as healthcare professionals and researchers work to develop more effective management strategies. The anticipated market growth reflects a heightened awareness of this condition and a growing need for specialized treatments and support.

One of the key factors driving the growth of the Whim Syndrome market is the increasing prevalence of this rare genetic disorder. Although Whim Syndrome is a rare disorder, the incidence of this condition is increasing. According to the National Organization for Rare Disorders (NORD), the incidence of Whim Syndrome is estimated to be around 1 in every 50,000 to 100,000 people worldwide.

Another factor driving the growth of the Whim Syndrome market is the increasing demand for effective treatment options. Currently, there are no approved treatments for Whim Syndrome. However, several companies are developing potential therapies for this rare disorder, and many of these treatments are in the late stages of clinical development.

In conclusion, the Whim Syndrome market is expected to grow significantly in the coming years, driven by the increasing prevalence of this rare genetic disorder and the growing demand for effective treatment options. As more treatments become available for Whim Syndrome, the demand for these treatments is expected to increase, driving the growth of this market.

Key Takeaways from the Market Study

From 2018 to 2022, the Whim Syndrome Management market grew at a CAGR of 4%.
The global Whim Syndrome Management market is expected to grow with a 6% CAGR during 2023 to 2033.
As of 2033, the Whim Syndrome Management Market is expected to reach US$ 17.91 Million.
According to the FMI analysis, hospital pharmacies account for the largest market share.
North America is expected to possess 40% market share for the Whim Syndrome Management market.
The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fuelling further clinical trials and research studies dedicated to discovering Whim Syndrome Management.” says an FMI analyst

Market Competition

Key players in the market include pharmaceutical companies such as X4 Pharmaceuticals, National Institute of Allergy and Infectious Diseases, GSK plc, Bristol Myers Squibb Company, F-Hoffmann La Roche Ltd., Pfizer Inc., Johnson and Johnson Services, Inc., Horizon Therapeutics plc, Amgen, and Leadiant Biosciences along with healthcare providers and technology companies among other global players.

Under the guidance of Philip Murphy, M.D. and David McDermott, M.D., researchers from the IRP have identified and enrolled three patients with advanced WHIM syndrome, who were ineligible for standard treatment, in an open-label study. These patients were administered low doses of plerixafor, and all three experienced a reduction in infection frequency and a significant enhancement in their quality of life. The utilization of plerixafor to treat WHIM syndrome is a new approach for patients who are unable to manage their symptoms using traditional therapies. Consequently, a randomized, double-blind Phase 3 trial has been developed to compare plerixafor to standard treatment, evaluate its clinical effectiveness, and gather additional safety information. You can find this trial on ClinicalTrials.gov with the identifier NCT02231879.

More Insights Available

FMI, in its new offering, presents an unbiased analysis of the global Whim Syndrome Management market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Drug Class, Route Administration, Distribution Channel & Region.

A Old Full Report Analysis Click Here

Key Segments Profiled in the Whim Syndrome Management Industry Survey

Drug Class:

Mavorixafor
Plerixafor

Route of Administration:

Oral
Parenteral
Injectable

Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube